Basking Biosciences, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2019-01-01
- Employees
- 1
- Market Cap
- -
Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
Phase 2
Recruiting
- Conditions
- Acute Ischemic Stroke
- Interventions
- Drug: BB-031Drug: Placebo
- First Posted Date
- 2024-01-26
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Basking Biosciences, Inc.
- Target Recruit Count
- 156
- Registration Number
- NCT06226805
- Locations
- 🇺🇸
Mills Peninsula Medical Center, Burlingame, California, United States
🇺🇸MemorialCare Long Beach Medical Center, Long Beach, California, United States
🇺🇸California Pacific Medical Center, San Francisco, California, United States
Study of DTRI-031 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy VolunteersPharmacokineticsPharmacodynamics
- Interventions
- Drug: DTRI-031Drug: Placebo
- First Posted Date
- 2021-08-13
- Last Posted Date
- 2022-07-19
- Lead Sponsor
- Basking Biosciences, Inc.
- Target Recruit Count
- 46
- Registration Number
- NCT05005520
- Locations
- 🇦🇺
Nucleus Network, Melbourne, Victoria, Australia
© Copyright 2025. All Rights Reserved by MedPath